Adjunctive Everolimus Treatment of Refractory Epilepsy

NCT05613166 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Everolimus
DRUG: Placebo

Sponsor

National Institute on Drug Dependence, China

Collaborators

[object Object]
[object Object]